AzTrials
AzTrials

Colonic AdenomaNCT03421600

Blue Laser Imaging and White Light Imaging Colonic Polyps

A study testing blue laser imaging and White light imaging in people with Colonic Adenoma and Colonoscopy, run by Changi General Hospital at 1 site in Singapore.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The adenoma detection rate by colonoscopy for asymptomatic individuals aged 50 years and older is estimated to be at least 25%. It is known that during colonoscopy, lesions may be missed. Image enhanced endoscopy techniques have been evaluated for the detection and differentiation of colonic polyps. Read more about this study

Who is it for?
Ages 50 years and older
Conditions the study is for
Colonic Adenoma, Colonoscopy
What is being tested?
blue laser imaging and White light imaging
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
184 participants
Where
1 siteSingapore
Study dates
12 Jul 2017to 22 Jul 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • An individual undergoing diagnostic colonoscopy
  • An individual undergoing screening colonoscopy

Who cannot join

  • Acute lower gastrointestinal bleeding
  • Familial colorectal cancer syndrome
  • Inflammatory bowel disease
  • Bloody diarrhoea
  • Colonic resection
  • Extensive abdominal or pelvic surgery where colonoscopy may be considered difficult
Show all 9Show fewer
  • Patients considered to be unsafe for biopsies or polypectomy due to bleeding tendency
  • Situations where complete colonoscopy cannot be completed or performed
  • Severe comorbid illnesses (ASA 3 and above)

Trial locations and contacts

1 site in 1 country.

Singapore1 site
  • Changi General Hospital

    Singapore, 529889

Other trials in Singapore

About this study

Official title: A Prospective Randomized Study of Colonoscopy Using Blue Laser Imaging and White Light Imaging in the Detection and Differentiation of Colonic Polyps

The adenoma detection rate by colonoscopy for asymptomatic individuals aged 50 years and older is estimated to be at least 25%. It is known that during colonoscopy, lesions may be missed. Image enhanced endoscopy techniques have been evaluated for the detection and differentiation of colonic polyps. Narrow band imaging (NBI), is one such technique. The common classification systems used predict histology is the NICE and the Sano and JNET classification. The NICE classification can be used without optical magnification; it evaluates the color of the lesion, regularity of the overlying vessels and regularity of the surface pattern. The Sano and JNET classification requires optical magnification in order to assess the capillary patterns such as whether there is dilation, irregularity or loss of irregular capillaries over the lesion. In the context of adenoma detection, the results are more contentious. A meta-analysis of randomized studies examining the utility of the first generation NBI system when compared to high definition WLI showed no difference in detection rates. A criticism of the NBI system had been the dark endoscopic view; this is a result of the optical filter, and can limit the far view. A second generation NBI system has since been developed. It is characterized by much brighter illumination despite the optical filter, and thus the far view is improved. A recent randomized controlled study compared the second-generation NBI system with high definition WLI. NBI was shown to improve polyp and adenoma detection rates compared to WLI. Blue laser imaging (BLI) is another form of narrow bandwidth imaging developed by Fujifilm Corporation (Tokyo, Japan). Instead of using an optical filter for white light to produce narrow bandwidths, the BLI system has a unique feature of illumination using two lasers and a white light phosphor to accomplish the visual enhancement of surface vessels and structures. This study aims to determine whether BLI can increase the detection rate of colonic polyps and adenomas when compared to white light endoscopy, with the null hypothesis being no difference in detection rates. This study will also examine the use of NICE and Sano/ JNET classification systems to predict histology with the BLI system.

Read the detailed description

BACKGROUND The adenoma detection rate by colonoscopy for asymptomatic individuals aged 50 years and older is estimated to be at least 25%. It is known that during colonoscopy, lesions may be missed. The miss rates for lesions depend on its size. In a meta-analysis, the overall miss rates for colonic polyps of any size was 22% (95% confidence interval [CI]: 19 - 26%) but based on size of adenomas, the miss rates ranged from 26% (95% CI: 21 - 30%) for lesions 1 - 5mm, to 13% (95% CI: 8 - 20%) for lesions 5 - 9mm and 2 (95% CI: 1 - 8%) for lesions larger than 10mm. Factors implicated in missed lesions include poor bowel preparation, short withdrawal time, lack of meticulous examination, and possibly subtle mucosal changes, especially for small or flat adenomas, that may be easily missed on white light imaging (WLI).

Image enhanced endoscopy techniques have been evaluated for the detection and differentiation of colonic polyps. Narrow band imaging (NBI), developed by Olympus Corporation (Tokyo, Japan) is one such technique and is a function available in all colonoscopies as a press button. When NBI is activated, an optical filter is applied to the white light source, such that only the narrow bandwidths of blue (440 - 460 nm) and green (540 - 560 nm) wavelengths are transmitted. These narrow bandwidths enhance the visualization of blood vessels and mucosal pit patterns. This technique has been shown to be useful in predicting colonic polyp histology and depth of mucosal invasion in the context of intra-mucosal cancer. The two common classification systems used predict histology is the NICE and the Sano classification. The NICE classification can be used without optical magnification; it evaluates the color of the lesion, regularity of the overlying vessels and regularity of the surface pattern. The Sano classification requires optical magnification in order to assess the capillary patterns such as whether there is dilation, irregularity or loss of irregular capillaries over the lesion. In the context of adenoma detection, the results are more contentious. A meta-analysis of randomized studies examining the utility of the first generation NBI system when compared to high definition WLI showed no difference in detection rates; it was only superior when compared to non high definition WLI, which may not be so relevant now since most new systems use high definition WLI. A criticism of the NBI system had been the dark endoscopic view; this is a result of the optical filter, and can limit the far view. A second generation NBI system has since been developed. It is characterized by much brighter illumination despite the optical filter, and thus the far view is improved. A recent randomized controlled study compared the second-generation NBI system with high definition WLI. NBI was shown to improve polyp and adenoma detection rates compared to WLI (adenoma: 48.3% vs. 34.4%, p = 0.01; polyps: 61.1% vs. 48.3%, p = 0.02).

Blue laser imaging (BLI) is another form of narrow bandwidth imaging developed by Fujifilm Corporation (Tokyo, Japan). It is a function integrated into the colonoscopy systems and can be activated and alternated with white light endoscopy by a push button. There is also optical magnification capability, thereby allowing detailed examination of micro-surface and micro-capillary structures. Instead of using an optical filter for white light to produce narrow bandwidths, the BLI system has a unique feature of illumination using two lasers and a white light phosphor to accomplish the visual enhancement of surface vessels and structures. A laser with a wavelength of 450nm stimulates the phosphor to irradiate a white-color illumination. The other laser, with a wavelength of 410nm, is used to enhance the blood vessels at shallow depth in the mucosa. Early data has shown its usefulness in predicting the histology of mucosal lesions. A comparative study showed that BLI had a greater far view compared to NBI due to its much brighter illumination. Thus far there has been no study to determine whether the use of BLI will increase the detection rate of colonic polyps and adenomas when compared to WLE. In addition, there has been no prior study of applying the NICE and Sano classifications developed using NBI to BLI. Recently in Japan a workgroup has proposed the JNET classification system to characterize polyps. This has not been applied using the BLI system either, being developed under NBI. Similar to Sano classification, this uses optical magnification. The main difference between the JNET and San classification systems is that in JNET classification system, Sano 2 is named JNET 2A, and Sano 3A is subsumed under JNET 2B, and Sano 3A becomes JNET 3.

AIM This study aims to determine whether BLI can increase the detection rate of colonic polyps and adenomas when compared to white light endoscopy, with the null hypothesis being no difference in detection rates. This study will also examine the use of NICE and Sano and JNET classification systems to predict histology with the BLI system.

METHODS This is a prospective randomized controlled study. Patients will be randomized in a 1:1 ratio in blocks of 10 to undergo either BLI or WLI colonoscopy. Randomization will be carried out by computer-generated random sequences. Once informed consent is obtained, the research assistant will disclose the assigned imaging technique (BLI or WLI) to the responsible endoscopist before the procedure.

Technique of colonoscopy and imaging All patients will be given dietary instructions before colonoscopy and will be prescribed four litres of polyethylene glycol in a split dose for bowel cleansing 1 day before colonoscopy. The Fujifilm colonoscope with WLI and BLI functions, and optical magnification capability (EC-L590ZW) and Fujifilm LASERO video endoscopy system, which supports WLI and BLI functions of the colonoscope, will be used. Colonoscopy will be performed under conscious sedation with intravenous midazolam and/or fentanyl. In the BLI group, insertion to cecum will be performed under WLI and once the cecum is reached, the BLI mode is switched on during withdrawal of endoscope for complete colonic examination. In the WLI group, WLI will be used during both insertion and withdrawal. Withdrawal time is defined as the time of the initiation of cecal inspection to the time when the colonoscope is completely removed from anus. The time for polypectomy will not be included. A dedicated research assistant measured the withdrawal time by using a stopwatch. The withdrawal time is set to a minimum of 6 min even in patients in whom no polyps are found. Bowel preparation of the whole colon will be graded according the Boston Bowel Preparation Scale which is routinely used in clinical practice and captured in the electronic reporting system.

The sizes and locations of all colonic polyps will be recorded contemporaneously. The locations of colonic lesions will be identified by anatomical landmarks or by transillumination. The size of colonic lesions will be measured against the span of an opened biopsy forceps. Regardless of the assigned group, once a polyp is detected during withdrawal, prior to removal, the surface structure of each polyp detected will be first assessed without optical magnification under BLI using the NICE classification. Thereafter optical magnification will be applied and the polyp will be classified using the Sano and JNET classification. Images will be captured electronically and stored in the electronic medical reporting system and can be retrieved for audit and verification and study of inter-observer agreement. All lesions will be resected or biopsied and labelled for histological examination. If more than 5 polyps are detected, the largest 5 polyps will be used for endoscopic-histological correlation. All procedures will be performed by either experienced endoscopists who have performed at least 1,000 colonoscopies or by endoscopy fellows under direct supervision of the experienced specialists. All endoscopists will have prior experience with image enhanced endoscopy using the NBI system. Prior to the start of the study, the NICE and Sano and JNET classifications will be formally reviewed with all participating endoscopists to ensure familiarity with these classifications for polyp assessment. To familiarize endoscopists with the BLI system, all endoscopists will be asked to carry out at least five examinations with the BLI system before performing study cases.

Definitions Complete colonoscopy is defined as successful cecal intubation. All colonic polyps removed during each examination will be sent for histological examination with clear labelling of location. Histological interpretation of all polyps will follow the World Health Organization system. Advanced adenoma will be defined as adenoma ≥ 10 mm in diameter, with any villous histology, high-grade dysplasia, or invasive carcinoma. Adenoma detection rate and polyp detection rate will be defined as the proportion of patients with at least one adenoma and one polyp respectively.

Outcomes The primary outcomes of this study will be the differences in adenoma (overall and flat) and polyp detection rates of BLI with WLI during diagnostic colonoscopy. Sub-analysis will be performed for the utility of NICE and Sano and JNET classification systems to predict histology with the BLI system.

Statistics We estimate the overall prevalence of colorectal adenoma in the WLI colonoscopy group to be 25%. In order to show a clinically important improvement of adenoma detection by BLI, the new system should increase the adenoma detection rate by 15%. With a statistical power of 80% and a two-sided significance level of 0.05, 152 patients will be needed in each study arm (total 304).

Adenoma detection rate or polyp detection rate will be calculated on the actual number of patients randomized to each group. Adenoma miss rate or polyp miss rate will be based on the percentage of patients who had completed the second colonoscopy. Bowel preparation will be regrouped into satisfactory (excellent to good) and unsatisfactory (fair to poor) for statistical analysis. The differences in detection rates between the BLI and WLI groups will be compared by the student's t-test. Statistical significance is taken as a two sided p value < 0.05. Factors associated with adenoma detection on first colonoscopy will be first identified by univariate analysis. Factors with a P value < 0.1 on univariate analysis will be further entered into forward stepwise logistic regression analysis. The adjusted odds ratio with 95% CI will be used to describe the influence of various factors on adenoma detection rate. All the above statistical analysis will be performed by SPSS statistics software (version 19.0, SPSS, Chicago, IL).

Using histology as gold standard, we will calculate the accuracy, sensitivity, specificity, and negative and positive predictive values for each component of the NICE and Sano and JNET classifications and for the overall prediction by using these classification systems. The differences in performance characteristics between the NICE and Sano and JNET classifications will be compared. To evaluate inter-observer variability in the diagnosis of colonic polyps using the NICE and Sano and JNET classifications a set of endoscopic digital images of histologically confirmed colonic polyps will be reviewed independently by the participating endoscopists. The k statistic, a measure of interobserver agreement over and above chance, will be calculated using the statistical software StatsDirect version 2.6.2 (Stats-Direct, Cheshire, UK). The strength of agreement is defined as follows: very good agreement: k more than 0.8 but less than 1; good agreement: k more than 0.6 but less than 0.8; moderate agreement: k more than 0.4 but less than 0.6; fair agreement: k more than 0.2 but less than 0.4; poor agreement: k less than 0.2.

Being tested
blue laser imaging, White light imaging
Keywords
image enhanced endoscopy, colonoscopy, colonic polyp, colonic adenoma
Medical subject headings
Colonic Polyps

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • blue laser imagingDevice

    blue laser imaging

  • White light imagingDevice

    White light imaging

Study groups in NCT03421600
Study groupRoleWhat they receive
Blue laser imagingActive comparatorBlue laser imaging
Receives: Device: blue laser imaging
White light imagingExperimentalWhite light imaging
Receives: Device: White light imaging

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. adenoma detection rate

    the proportion of patients who had an adenoma detected

    Measured: Through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Feb 2018
  2. Study start12 Jul 2017
  3. Primary completion22 Jul 2019
  4. Study completion22 Jul 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Screening
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
184 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03421600
Sponsor's protocol ID
CIRB 2016/3054
Status last verified
Jan 2020
First submitted
28 Mar 2017
Last updated
23 Jan 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Ang TL, Fock KM. Screening Colonoscopy for Average Risk Individuals in Singapore. Intest Res 2012; 10: 219-228.

  • Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993 Dec 30;329(27):1977-81. doi: 10.1056/NEJM199312303292701.

    PubMed 8247072
  • Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, Shi W, Bond JH, Schapiro M, Panish JF, Stewart ET, Waye JD. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012 Feb 23;366(8):687-96. doi: 10.1056/NEJMoa1100370.

    PubMed 22356322
  • ASGE Standards of Practice Committee; Fisher DA, Shergill AK, Early DS, Acosta RD, Chandrasekhara V, Chathadi KV, Decker GA, Evans JA, Fanelli RD, Foley KQ, Fonkalsrud L, Hwang JH, Jue T, Khashab MA, Lightdale JR, Muthusamy VR, Pasha SF, Saltzman JR, Sharaf R, Cash BD. Role of endoscopy in the staging and management of colorectal cancer. Gastrointest Endosc. 2013 Jul;78(1):8-12. doi: 10.1016/j.gie.2013.04.163. Epub 2013 May 7. No abstract available.

    PubMed 23664162
  • Rex DK, Schoenfeld PS, Cohen J, Pike IM, Adler DG, Fennerty MB, Lieb JG 2nd, Park WG, Rizk MK, Sawhney MS, Shaheen NJ, Wani S, Weinberg DS. Quality indicators for colonoscopy. Gastrointest Endosc. 2015 Jan;81(1):31-53. doi: 10.1016/j.gie.2014.07.058. Epub 2014 Dec 2. No abstract available.

    PubMed 25480100
  • van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol. 2006 Feb;101(2):343-50. doi: 10.1111/j.1572-0241.2006.00390.x.

    PubMed 16454841
  • Hassan C, Bretthauer M, Kaminski MF, Polkowski M, Rembacken B, Saunders B, Benamouzig R, Holme O, Green S, Kuiper T, Marmo R, Omar M, Petruzziello L, Spada C, Zullo A, Dumonceau JM; European Society of Gastrointestinal Endoscopy. Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2013;45(2):142-50. doi: 10.1055/s-0032-1326186. Epub 2013 Jan 18.

    PubMed 23335011
  • Barclay RL, Vicari JJ, Doughty AS, Johanson JF, Greenlaw RL. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med. 2006 Dec 14;355(24):2533-41. doi: 10.1056/NEJMoa055498.

    PubMed 17167136
  • Lee RH, Tang RS, Muthusamy VR, Ho SB, Shah NK, Wetzel L, Bain AS, Mackintosh EE, Paek AM, Crissien AM, Saraf LJ, Kalmaz DM, Savides TJ. Quality of colonoscopy withdrawal technique and variability in adenoma detection rates (with videos). Gastrointest Endosc. 2011 Jul;74(1):128-34. doi: 10.1016/j.gie.2011.03.003. Epub 2011 Apr 30.

    PubMed 21531410
  • Hewett DG, Kaltenbach T, Sano Y, Tanaka S, Saunders BP, Ponchon T, Soetikno R, Rex DK. Validation of a simple classification system for endoscopic diagnosis of small colorectal polyps using narrow-band imaging. Gastroenterology. 2012 Sep;143(3):599-607.e1. doi: 10.1053/j.gastro.2012.05.006. Epub 2012 May 15.

    PubMed 22609383
  • Hayashi N, Tanaka S, Hewett DG, Kaltenbach TR, Sano Y, Ponchon T, Saunders BP, Rex DK, Soetikno RM. Endoscopic prediction of deep submucosal invasive carcinoma: validation of the narrow-band imaging international colorectal endoscopic (NICE) classification. Gastrointest Endosc. 2013 Oct;78(4):625-32. doi: 10.1016/j.gie.2013.04.185. Epub 2013 Jul 30.

    PubMed 23910062
  • McGill SK, Evangelou E, Ioannidis JP, Soetikno RM, Kaltenbach T. Narrow band imaging to differentiate neoplastic and non-neoplastic colorectal polyps in real time: a meta-analysis of diagnostic operating characteristics. Gut. 2013 Dec;62(12):1704-13. doi: 10.1136/gutjnl-2012-303965. Epub 2013 Jan 7.

    PubMed 23300139
  • ASGE Technology Committee; Abu Dayyeh BK, Thosani N, Konda V, Wallace MB, Rex DK, Chauhan SS, Hwang JH, Komanduri S, Manfredi M, Maple JT, Murad FM, Siddiqui UD, Banerjee S. ASGE Technology Committee systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting real-time endoscopic assessment of the histology of diminutive colorectal polyps. Gastrointest Endosc. 2015 Mar;81(3):502.e1-502.e16. doi: 10.1016/j.gie.2014.12.022. Epub 2015 Jan 16.

    PubMed 25597420
  • Sano Y, Ikematsu H, Fu KI, Emura F, Katagiri A, Horimatsu T, Kaneko K, Soetikno R, Yoshida S. Meshed capillary vessels by use of narrow-band imaging for differential diagnosis of small colorectal polyps. Gastrointest Endosc. 2009 Feb;69(2):278-83. doi: 10.1016/j.gie.2008.04.066. Epub 2008 Oct 25.

    PubMed 18951131
  • Ikematsu H, Matsuda T, Emura F, Saito Y, Uraoka T, Fu KI, Kaneko K, Ochiai A, Fujimori T, Sano Y. Efficacy of capillary pattern type IIIA/IIIB by magnifying narrow band imaging for estimating depth of invasion of early colorectal neoplasms. BMC Gastroenterol. 2010 Mar 27;10:33. doi: 10.1186/1471-230X-10-33.

    PubMed 20346170

Questions about this trial

What is this clinical trial studying?

A study testing blue laser imaging and White light imaging in people with Colonic Adenoma and Colonoscopy, run by Changi General Hospital at 1 site in Singapore.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

adenoma detection rate (time frame: Through study completion, an average of 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03421600, which also lists 29 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jan 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in